Explore the latest in COPD, including recent guidelines and advances in prevention, diagnosis, and medical and procedural treatments.
This randomized clinical trial compares the effects of a program combining transition and long-term self-management support vs transition support alone on 6-month hospitalizations and emergency department visits among patients with chronic obstructive pulmonary disease (COPD).
This randomized clinical trial compares the effects of adding theophylline vs placebo to inhaled corticosteroids (ICS) treatment on prevention of exacerbations in patients with chronic obstructive pulmonary disease (COPD).
This randomized clinical trial compares the effect of long-term nicotine replacement therapy vs standard smoking cessation on exposure to cigarette smoke, harm related to smoking, and smoking cessation among smokers with chronic obstructive pulmonary disease.
This study examines the frequency of steroid use for acute respiratory tract infections in Louisiana and nationally, and factors associated with this clinical practice.
A 64-year-old man with a family history of early-onset lung disease, presented with dyspnea and recurrent pneumonia, emphysema changes on CT, and a serum α1-antitrypsin concentration of 14 mg/dL. How would you interpret the result?
In this study, Global Burden of Disease investigators characterize trends in mortality, life expectancy, and prevalence associated with most common diseases and disease and mortality risk factors in the United States between 1990 and 2016.
This nested case-control study investigates the risk of cardiovascular disease associated with long-acting β2-agonists and long-acting antimuscarinic antagonists, focusing on the initiation and duration of both therapies.
This JAMA Clinical Guidelines Synopsis summarizes the 2017 Global Initiative for Chronic Obstructive Lung Disease guideline on screening for chronic obstructive pulmonary disorder.
This Clinical Evidence Synopsis summarizes a Cochrane review on the efficacy of long-acting β-agonists (LABAs) combined with long-acting muscarinic antagonists vs LABAs combined with inhaled corticosteroids for patients with stable chronic obstructive pulmonary disease.
This population epidemiology study estimates county-level patterns in mortality rates for chronic respiratory diseases in the United States from 1980 through 2014.
This randomized clinical trial compares the effects of home oxygen therapy with vs without home noninvasive ventilation (NIV) on time to readmission or death in patients with persistent hypercapnia after an acute chronic obstructive pulmonary disease (COPD) exacerbation.
This Viewpoint reviews the importance of physical inspection on, or shortly after, initial contact with a patient.
This study examines coverage and cost-sharing for chronic obstructive pulmonary disease inhalers in Medicare Part D plans.
A man with chronic obstructive pulmonary disease and worsening dyspnea has pulmonary hypertension by right heart catheterization, a nonocclusive left femoral and popliteal thrombus, and a large mismatch defect on V/Q scan. What would you do next?
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: